Evaluation of graft-versus-host disease based on measurement of HLA levels in the plasma of allogeneic bone marrow recipients
暂无分享,去创建一个
L. Mendeleeva | V. Savchenko | L. Golovkina | E. A. Zotikov | M. N. Vasil’eva | L. S. Lyubimova | L. P. Poreshina | R. M. Kut'ina
[1] R. Calne,et al. Soluble class I antigen in human bile. , 1989, Transplantation.
[2] H. Deeg,et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. , 1989, Blood.
[3] J. Klein,et al. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen , 1987 .
[4] R. Hackman,et al. A PROSPECTIVE STUDY OF UNEXPLAINED NAUSEA AND VOMITING AFTER MARROW TRANSPLANTATION , 1986, Transplantation.
[5] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[6] R. Storb,et al. Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.
[7] J. Yardley,et al. Deficiency of intestinal immunity with graft-vs.-host disease in humans. , 1981, The Journal of infectious diseases.
[8] Slavin Re,et al. The pathology of bone marrow transplantation. , 1974 .